Rickettsial Disease — Causes of Fever in Bangladeshi Patients
Citation(s)
Blacksell SD, Bryant NJ, Paris DH, Doust JA, Sakoda Y, Day NP Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion. Clin Infect Dis. 2007 Feb 1;44(3):391-401. Epub 2007 Jan 3. Review.
Civen R, Ngo V Murine typhus: an unrecognized suburban vectorborne disease. Clin Infect Dis. 2008 Mar 15;46(6):913-8. doi: 10.1086/527443. Review.
Henry KM, Jiang J, Rozmajzl PJ, Azad AF, Macaluso KR, Richards AL Development of quantitative real-time PCR assays to detect Rickettsia typhi and Rickettsia felis, the causative agents of murine typhus and flea-borne spotted fever. Mol Cell Probes. 2007 Feb;21(1):17-23. Epub 2006 Jul 1.
Kim DM, Kim SW, Choi SH, Yun NR Clinical and laboratory findings associated with severe scrub typhus. BMC Infect Dis. 2010 Apr 30;10:108. doi: 10.1186/1471-2334-10-108.
LEVINE HD Pathologic study of thirty-one cases of scrub typhus fever with especial reference to the cardiovascular system. Am Heart J. 1946 Mar;31:314-28.
Rovery C, Brouqui P, Raoult D Questions on Mediterranean spotted fever a century after its discovery. Emerg Infect Dis. 2008 Sep;14(9):1360-7. doi: 10.3201/eid1409.071133.
Sirisanthana V, Puthanakit T, Sirisanthana T Epidemiologic, clinical and laboratory features of scrub typhus in thirty Thai children. Pediatr Infect Dis J. 2003 Apr;22(4):341-5.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
